Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | STAT6 | P42226 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.31 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adamantane SCHEMBL28003802 | 0.94 | CYP2C9 (0.38) | CYP2C9LMNA | |
| Adamantane SCHEMBL7154373 | 0.94 | CYP2C9 (0.38) | CYP2C9LMNA | |
| Adamantane SCHEMBL8848421 | 0.94 | CYP2C9 (0.43) | CYP2C9SLC22A2SLC22A1GRIN2DGRIN3B | |
| Adamantane SCHEMBL870112 | 0.94 | CYP2C9 (0.43) | CYP2C9SLC22A2SLC22A1GRIN2DGRIN3B | |
| Adamantane SCHEMBL913610 | 0.94 | CYP2C9 (0.43) | CYP2C9SLC22A2SLC22A1GRIN2DGRIN3B | |
| Adamantane SCHEMBL28551331 | 0.88 | CYP2C9 (0.40) | CYP2C9SLC22A2SLC22A1GRIN2DGRIN3B | |
| Adamantane SCHEMBL28330886 | 0.88 | CYP2C9 (0.40) | CYP2C9SLC22A2SLC22A1GRIN2DGRIN3B | |
| Adamantane SCHEMBL21433651 | 0.88 | CYP2C9 (0.40) | CYP2C9SLC22A2SLC22A1GRIN2DGRIN3B | |
| Adamantane SCHEMBL18065809 | 0.88 | CYP2C9 (0.40) | CYP2C9SLC22A2SLC22A1GRIN2DGRIN3B | |
| Adamantane SCHEMBL28232364 | 0.88 | CYP2C9 (0.40) | CYP2C9SLC22A2SLC22A1GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011687-A | High-toughness epoxy resin-based carbon fiber prepreg and preparation method thereof | 江苏美伦新材料科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-116217484-B | Naphthalimide derivative based on methylene adamantane modification as well as preparation method and application thereof | 苏州大学 | 2024-04-05 | — | — | CN | claimed |
| CN-116395671-A | Preparation method of magnetic carbon quantum dot with high relaxation rate | 中国科学院上海微系统与信息技术研究所 | 2023-07-07 | — | — | CN | claimed |
| CN-116285974-A | Preparation method of carbon-based quantum dot with high quantum yield and light stability | 中国科学院上海微系统与信息技术研究所 | 2023-06-23 | — | — | CN | claimed |
| CN-116217484-A | Naphthalimide derivative based on methylene adamantane modification as well as preparation method and application thereof | 苏州大学 | 2023-06-06 | — | — | CN | claimed |
| CN-106478849-A | Catalytic component for vinyl polymerization and ethylene rolymerization catalyst | 中国石油化工股份有限公司 | 2017-03-08 | — | — | CN | claimed |
| CN-106478850-A | Preparation method and ethylene rolymerization catalyst for the catalytic component of vinyl polymerization | 中国石油化工股份有限公司 | 2017-03-08 | — | — | CN | claimed |
| US-8481016-B2 | Method for inhibition of potential-dependent cation channel | KAO CORPORATION (JP) | 2013-07-09 | — | — | US | claimed |
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | KAO CORPORATION (JP) | 2013-02-21 | — | — | US | claimed |
| CN-102258788-B | Targeted transmission assembly of adriamycin anticancer medicine and preparation method thereof | UNIV NANKAI | 2012-11-07 | — | — | CN | claimed |
| CN-102258788-A | Targeted transmission assembly of adriamycin anticancer medicine and preparation method thereof | — | 2011-11-30 | — | — | CN | claimed |
| CN-1665801-B | Anti tubercular drug: compositions and methods | DEPT OF HEALTH AND HUMAN SERVI | 2011-05-11 | — | — | CN | claimed |
| CN-122011687-A | High-toughness epoxy resin-based carbon fiber prepreg and preparation method thereof | 江苏美伦新材料科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4714935-A1 | AROMATIC COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPARATUS | Hodogaya Chemical Co., Ltd. (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12582641-B2 | Sulfur-containing compound based on glutarimide skeleton and application thereof | SHANGHAITECH UNIVERSITY (CN) | 2026-03-24 | — | — | US | disclosed |
| CN-116874408-B | Adamantane-modified fullerene (C) with enhanced fluorescence properties60) Pyrrolidine, microcrystal thereof and preparation method thereof | 山东大学 | 2026-03-20 | — | — | CN | disclosed |
| CN-1284057-A | Adamantane derivatives | ASTRA ZENECA BRITISH LTD (GB) | 2001-02-14 | — | — | CN | disclosed |
| CN-1202888-A | Isoquinoline derivatives and isoquinoline combinatorial libraries | TORREY PINES INST (US) | 1998-12-23 | — | — | CN | disclosed |
| CN-1155546-A | Aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]-indol-8-ones and derivatives | AMERICAN HOME PROD (US) | 1997-07-30 | — | — | CN | disclosed |
| EP-0240631-A1 | Alkylation of amines and amides | ETHYL CORPORATION (US) | 1987-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | TRPM7, TRPM8, OR10J3 | CYP2C9 795/4885SLC22A2 1777/4885SLC22A1 1732/4885 |
| US-12582641-B2 | Sulfur-containing compound based on glutarimide skeleton and application thereof | SUCNR1, SRD5A1, GLS | CYP2C9 2079/4885SLC22A2 1299/4885SLC22A1 898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.